CN1183918C - Medicine for curing protrution of intervetebral disc and its preparing method - Google Patents
Medicine for curing protrution of intervetebral disc and its preparing method Download PDFInfo
- Publication number
- CN1183918C CN1183918C CNB001032178A CN00103217A CN1183918C CN 1183918 C CN1183918 C CN 1183918C CN B001032178 A CNB001032178 A CN B001032178A CN 00103217 A CN00103217 A CN 00103217A CN 1183918 C CN1183918 C CN 1183918C
- Authority
- CN
- China
- Prior art keywords
- medicine
- present
- intervertebral disk
- treatment
- disk hernia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a new medicine for treating intervertebral disk hernia. The present invention is a pure Chinese medicine preparation and is prepared by calcined cocoons, scorpions, raw nux vomica, achyranthes roots, Chinese ephedra, frankincense, myrrh, licorice roots, atractylodes rhizomes, safflowers, coralbean bark, pangolin, etc. according to a proportion; all the component medicines are processed according to different characteristics of the medicines and then made into various preparations, such as capsules. The present invention has the advantages of unique prescription and preparation method, treatment of both manifestation and root causes of diseases and conspicuous curative effect.
Description
The present invention relates to a kind of medicine for the treatment of intervertebral disk hernia, be specifically a kind of be the pure Chinese medicinal preparation of the treatment intervertebral disk hernia disease made of raw material with the natural Chinese medicinal herb, the invention still further relates to the preparation method of this medicine.
Intervertebral disk hernia is meant that the fibrous ring of intervertebral disc is broken and nucleus pulposus outstanding, stimulates the nerve root with compressing spinal dura mater and corresponding site, causes a series of sings and symptoms.This disease is the common multiple disease of harm humans health, has directly influenced patient's daily life.This disease shows as regression and loose intervertebral disc canalis spinalis bulging in the early stage, and the patient has pain, and when serious, fibrous ring is broken, even becomes free piece, and changes such as hyperemia, edema, adhesion take place nerve root, and at this moment, the patient can't take care of oneself.Its characteristics of incidence is, disease patient man is more than the woman, and person between twenty and fifty account for 80%, and more than half the waist injury history arranged.
Have some now and treat the method for this type of disease, all have to have such or such deficiency, effect is unsatisfactory.As use the massage therapy maneuver unpunctual, complication such as cauda equina injury can occur, and central type intervertebral disk hernia disease also should not be used massage therapy; As for injection treatment, present employed injection can only make the disease respite, takes stopgap measures and does not effect a permanent cure; And,, patient's health is had certain requirement, and also inapplicable this therapy of central type compressing though the fast characteristics of curing are arranged for surgical therapy.
The object of the present invention is to provide a kind of medicament for the treatment of intervertebral disk hernia, it is applicable to various types of intervertebral disc prolapse, and dosage is little, and the cycle of taking is short, taking convenience, and instant effect, toxic and side effects is little.
Solution of the present invention is according to medicine principle, clinical experience through two more than ten years, learn wildly from other's strong points, select the essence, based on pathogenetic understanding and Therapeutic Principle to intervertebral disk hernia, with reference to the modern pharmacological research achievement, but from motherland's medical treasure-house, choose the natural drug of Synergistic treatment intervertebral disk hernia and hyperosteogeny, according to the theory of Chinese medical science prescription, each medicine synergism of distinguishing the flavor of, the function of scalable human body, activating blood circulation to dissipate blood stasis improves the blood supply ability of body to intervertebral disc, impels the intervertebral disc active homing.And can effectively prevent hyperosteogeny, and further regulate vertebral pulp, can avoid vertebral pulp atrophy, machineization, calcification, to reach curative effect.
The present invention treats the medicine of intervertebral disk hernia and makes (consumption is a weight portion) by the following branch of forming:
Bombyx Batryticatus 0.5~1.2 Scorpio, 0.5~1.2 Semen Strychni (life) 40~80
Radix Achyranthis Bidentatae 0.5~1.2 Herba Ephedrae 0.5~1.2 Olibanum 0.5~1.2
Myrrha 0.5~1.5 Radix Glycyrrhizae 0.5~1.2 Rhizoma Atractylodis 0.5~1.2
Flos Carthami 0.5~1.2 Cortex erythrinae, 0.5~1.2 Squama Manis (process of preparing Chinese medicine) 0.5~1.2
Preferred weight (part) ratio range of preparation medicine of the present invention is:
Bombyx Batryticatus 1 Scorpio, 1 Semen Strychni (life) 62.5
Radix Achyranthis Bidentatae 1 Herba Ephedrae 1 Olibanum 1
Myrrha 1 Radix Glycyrrhizae 1 Rhizoma Atractylodis 1
Flos Carthami 1 Cortex erythrinae, 1 Squama Manis (process of preparing Chinese medicine) 1
Each flavor of medicine of the present invention is crude drug, starts with from the cause of disease of intervertebral disk hernia, according to cause of disease medication, can effectively alleviate the compressing of intervertebral disc to nerve root, removes the adhesion of flesh rib.Medicine of the present invention has activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain, and resetting of intervertebral disc etc. had significant curative effect.The present invention can make various dosage forms according to a conventional method.
Preferred a kind of capsule formulation of making by special process in various dosage forms, preparation method is as follows:
Take by weighing the crude drug of respectively distinguishing the flavor of by prescription, dry, pulverize, sieve.After residual medicine dreg decocted with water, filters, filtrate is concentrated the back add medicated powder, the back airing that stirs incapsulates after the pulverizing and gets final product.
The preferred for preparation method:
1) takes by weighing the crude drug of respectively distinguishing the flavor of by prescription, get Radix Achyranthis Bidentatae, Radix Glycyrrhizae, Herba Ephedrae, Rhizoma Atractylodis, Cortex erythrinae, Scorpio, Bombyx Batryticatus and be put in the pot, fry yellowly and get final product.
2) will add the Semen phaseoli radiati steaming and decocting simultaneously of 1/4th amounts in the Semen Strychni, till blooming to Semen phaseoli radiati, take out the Semen Strychni peeling, cut into slices, dry, the yellow old city of reuse parching with earth to heavy black gets final product.
3) it is stand-by that Olibanum, Myrrha are pressed the process of preparing Chinese medicine of Chinese medicine mechanism.
4) above-mentioned all medicament mixed are ground into fine powder 120 orders, incapsulate (every ball 0.5 gram) and get final product.
Because the position and the pathologic condition of patient's intervertebral disk hernia differ, innervation exists interlaced again, and diversity is very big, can use electromyogram, canalis spinalis B ultrasonic, magnetic resonance, CT etc. to check diagnosis.
Instructions of taking: consumption: every day, 1-6 restrained, and is oral every day 2 times, takes take medicine 1-2 the course of treatment (be 1 month each course of treatment) with yellow wine.
Statistical standard is as shown in table 1, and curative effect clinical data statistics is as shown in table 2.
Table 1 clinical statistics standard
Produce effects | Effectively | Invalid | |
Intervertebral disk hernia | Clinical symptoms all or substantially disappears, and physical examination slightly should disease influence remnants. | Clinical symptoms is most of to disappear or improvement, and this disease influence exists. | Clinical symptoms and sign do not have significant change. |
Table 2 curative effect clinical data statistics
Disease | Case load | Produce effects | Effectively | Invalid | Effective percentage | |
Intervertebral disk hernia | The man | 442 | 402 | 30 | 10 | 97.7% |
The woman | 375 | 340 | 27 | 8 | 97.8% |
Capsule preparations of medicine of the present invention and preparation method thereof is got the length of each dosage form, mends its weak point again, promptly reduces volume, has improved drug effect again.The per 4 pill capsule preparations of medicine of the present invention (every ball 0.5 gram) are equivalent to the efficacy of a drug of 30 gram crude drugs.Therefore taking convenience, instant effect, effect be lasting, have no side effect.Medicine of the present invention has significant curative effect to the intervertebral disc prolapse of central type compressing
By above-mentioned clinical data as seen, medicine of the present invention has curative effect preferably for treatment intervertebral disk hernia disease.
Model case:
1. tall generation outstanding person, the man, 62 years old now, Zhengzhou City pipe people from city, two upper limb and right lower extremity numb pain 4 years are surplus, can't take care of oneself during prescription on individual diagnosis, once in Zhengzhou, how tame large hospital treatment such as Beijing, Shanghai, poor effect, and arrange testament three times, want remains are handed over Henan Medical Univ.'s research, I go to a doctor at institute in July, 1998, diagnosis: prolapse of cervical intervertebral disc, calcification, the central type compressing can not be by operative treatment, oral medicament of the present invention also is aided with the traction physical therapy, through controlling 48 days, full recovery function, normally working.
Yang Xiaoqiang, the man, 46 years old, the Erqi District people of Zhengzhou City suffered from intervertebral disc prolapse, and go to a doctor in my institute and check, oral medicament of the present invention 40 days, symptom all disappears, and recovers operate as normal.
Claims (3)
1, a kind of medicine for the treatment of intervertebral disk hernia is characterized in that it is made by the following weight proportion raw material:
Bombyx Batryticatus 0.5~1.2 Scorpio 0.5~1.2 Semen Strychni 40~80
Radix Achyranthis Bidentatae 0.5~1.2 Herba Ephedrae 0.5~1.2 Olibanum 0.5~1.2
Myrrha 0.5~1.5 Radix Glycyrrhizae 0.5~1.2 Rhizoma Atractylodis 0.5~1.2
The Squama Manis 0.5~1.2 of Flos Carthami 0.5~1.2 Cortex erythrinae 0.5~1.2 through concocting.
2, the medicine of treatment intervertebral disk hernia according to claim 1, wherein the weight proportion of each raw material is:
Bombyx Batryticatus 1 Scorpio 1 Semen Strychni 62.5
Radix Achyranthis Bidentatae 1 Herba Ephedrae 1 Olibanum 1
Myrrha 1 Radix Glycyrrhizae 1 Rhizoma Atractylodis 1
The Squama Manis 1 of Flos Carthami 1 Cortex erythrinae 1 through concocting.
3, the medicine of treatment intervertebral disk hernia according to claim 2, the dosage form that it is characterized in that it is a capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001032178A CN1183918C (en) | 2000-03-20 | 2000-03-20 | Medicine for curing protrution of intervetebral disc and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001032178A CN1183918C (en) | 2000-03-20 | 2000-03-20 | Medicine for curing protrution of intervetebral disc and its preparing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1314159A CN1314159A (en) | 2001-09-26 |
CN1183918C true CN1183918C (en) | 2005-01-12 |
Family
ID=4576821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001032178A Expired - Fee Related CN1183918C (en) | 2000-03-20 | 2000-03-20 | Medicine for curing protrution of intervetebral disc and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1183918C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832929A (en) * | 2016-04-26 | 2016-08-10 | 于龙 | Traditional Chinese medicine decoction for treating lumbar disc herniation |
-
2000
- 2000-03-20 CN CNB001032178A patent/CN1183918C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1314159A (en) | 2001-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
CN101757569A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and cerebral infarction and preparation method thereof | |
CN1141127C (en) | Medicine for treating protrusion of cervical and lumbar intervertebral disc | |
CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN102698024B (en) | Oral traditional Chinese medicine preparation for treating postoperative intestinal adhesion | |
CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
CN102008666B (en) | Drug for treating lumbocrural pain | |
CN102038930A (en) | Medicament for treating protrusion of lumbar vertebral disc | |
CN102512645A (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
CN102370688A (en) | Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof | |
CN102698130B (en) | Traditional Chinese medicine extract for treating postoperative intestinal adhesion | |
CN101961448A (en) | Chinese medicament for treating diabetic gout | |
CN105435210A (en) | Traditional Chinese medicine oriented permeable drug treatment liquid for treating cold-dampness stasis type lumbar disc herniation and preparation method thereof | |
CN101850019A (en) | Chinese medicament for treating diabetic acromelic gangrene | |
CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
CN106729443A (en) | A kind of Chinese medicine composition for swelling and pain relieving and preparation method thereof | |
CN101502597A (en) | Medicament for treating stomachache and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Huang Qingzhuo Document name: Notice of conformity |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050112 Termination date: 20100320 |